Background: Allergic asthmatics develop isolated late asthmatic reactions after inhalation of allergen- derived T-cell peptides. Animal experiments have shown that airway hyperresponsiveness is CD4+ cell-dependent. We hypothesise that peptide inhalation produces increases in non-specific airway hyperresponsiveness (AHR) and a T-cell dominant, bronchial mucosal inflammatory response.
Methods: Bronchoscopy, with bronchial biopsies and bronchoalveolar lavage (BAL), was performed in 24 cat-allergic subjects 6 hours after aerosol inhalation of short overlapping peptides derived from Fel d 1, the major cat allergen. Biopsies and BAL were studied using immunohistochemistry and ELISA.
Results: Twelve of the 24 subjects developed an isolated late asthmatic reaction without a preceding early- (mast cell/histamine-dependent) reaction characteristic of whole allergen inhalation. These responders had a significant between-group differences (responders vs non-responders) in the changes (peptide vs diluent) in AHR (p= 0.007) and bronchial mucosal CD3+ (p=0.005), CD4+ (p=0.006) and TARC+ (p=0.003) but not CD8+ or CD25+ cells or eosinophils, basophils, mast cells and macrophages. The between-group difference for neutrophils was p=0.05 but with a non-significant within group value (peptide vs diluent, responders, p=0.11). In BAL there was a significant between-group difference in TARC (p=0.02) but not in histamine, tryptase, basogranulin, C3a or C5a, LTC4/D4/E4, PGD2 or PGF2α.
Conclusions: Direct activation of allergen- specific airway T cells by peptide inhalation in atopic asthmatics leads to increased airway hyperresponsiveness with local increases in CD3+ and CD4+ cells and TARC but no significant changes in eosinophils or basophil/mast cell products thereby supporting previous animal experiments which showed a CD4+ dependence for airway hyperresponsiveness.
- T cells
- airway hyperresponsiveness
- late asthmatic reactions
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.